Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
Google Scholar
Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351: h4901.
Article
Google Scholar
Sopik V, Nofech-Mozes S, Sun P, Narod SA. The relationship between local recurrence and death in early-stage breast cancer. Breast Cancer Res Treat. 2016;155(1):175–85.
Article
Google Scholar
Borstkanker in Nederland - trends 1989–2019 gebaseerd op cijfers uit de Nederlandse Kankerregistratie https://iknl.nl/getmedia/2f489dc8-a103-4fd6-89fe-e266e589366f/borstkanker-in-nederland_flyer_2020.pdf. Accessed March 25 2021.
FMS. Federatie Medisch Specialisten. Borstkanker - Screening binnen het BOB https://richtlijnendatabase.nl/richtlijn/borstkanker/screening/screening_binnen_het_bob.html. Accessed July 5 2021.
FMS. Federatie Medisch Specialisten. Borstkanker - Screening buiten het BOB https://richtlijnendatabase.nl/richtlijn/borstkanker/screening/screening_buiten_het_bob.html. Accessed July 5 2021.
Schunemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nystrom L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Grawingholt A, Saz-Parkinson Z, European Commission Initiative on Breast Cancer Contributor G. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med. 2020;172(1):46–56.
Article
Google Scholar
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R, American CS. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA. 2015;314(15):1599–614.
Article
CAS
Google Scholar
Siu AL, Force USPST. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279–96.
Article
Google Scholar
Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev. 2018;39:7.
Article
Google Scholar
NICE. National Institute for Health and Care Excellence - Early detection of breast cancer by surveillance https://www.nice.org.uk/guidance/cg164/ifp/chapter/early-detection-of-breast-cancer-by-surveillance#:~:text=If%20you%20have%20breast%20cancer,have%20a%20faulty%20TP53%20gene. Accessed July 5 2021.
Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collee M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems M, Seynaeve C, Rookus MA, Hooning MJ. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019;177(3):723–33.
Article
CAS
Google Scholar
IKNL. Integraal Kankercentrum Nederland - Borstkanker in Nederland https://iknl.nl/getmedia/66740392-399a-43f9-8366-b4f51ade7b09/IKNL_Rapport-Borstkanker-in-Nederland-sept2020.pdf. Accessed July 5 2021.
Patuleia SIS, Suijkerbuijk KPM, van der Wall E, van Diest PJ, Moelans CB. Nipple aspirate fluid at a glance. Cancers (Basel). 2021;14(1):159.
Article
Google Scholar
Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.
Article
CAS
Google Scholar
Zubor P, Kubatka P, Kajo K, Dankova Z, Polacek H, Bielik T, et al. Why the gold standard approach by mammography demands extension by multiomics? Application of liquid biopsy miRNA profiles to breast cancer disease management. Int J Mol Sci. 2019;20(12):2878.
Article
Google Scholar
Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clin Proteomics. 2018;15:3.
Article
Google Scholar
Mendat CC, Mislan D, Hession-Kunz L. Patient comfort from the technologist perspective: factors to consider in mammographic imaging. Int J Womens Health. 2017;9:359–64.
Article
Google Scholar
Van Goethem M, Mortelmans D, Bruyninckx E, Verslegers I, Biltjes I, Van Hove E, De Schepper A. Influence of the radiographer on the pain felt during mammography. Eur Radiol. 2003;13(10):2384–9.
Article
Google Scholar
Papanicolaou GN, Holmquist DG, Bader GM, Falk EA. Exioliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer. 1958;11(2):377–409.
Article
CAS
Google Scholar
Kitchen FL, Cox CM. Papanicolaou Smear. Treasure Island: StatPearls; 2021.
Suijkerbuijk KP, van der Wall E, van Diest PJ. Oxytocin: bringing magic into nipple aspiration. Ann Oncol. 2007;18(10):1743–4.
Article
CAS
Google Scholar
Suijkerbuijk KP, van der Wall E, Meijrink H, Pan X, Borel Rinkes IH, Ausems MG, van Diest PJ. Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer. Fam Cancer. 2010;9(3):321–5.
Article
Google Scholar
Netherlands Trial Register: Trial NL8661. NAF study: early detection of hereditary breast cancer by monitoring microRNA expression in nipple aspirate fluid. https://www.trialregister.nl/trial/8661. Accessed July 5 2021.
Netherlands Trial Register: Trial NL6031. The ORNAMENT study: A multicenter, crOss sectional, study to assess microRNA expression in Nipple Aspirated Fluid, blood and tuMor material in women with primary brEast caNcer compared with healthy conTrols. https://www.trialregister.nl/trial/6031. Accessed July 5 2021.
Netherlands Trial Register: Trial NL8987. Breast Cancer Biomarkers in Nipple Aspirate Fluid and Blood in Healthy Women. https://www.trialregister.nl/trial/8987. Accessed July 5 2021.
de Groot JS, Moelans CB, Elias SG, Hennink A, Verolme B, Suijkerbuijk KP, Jager A, Seynaeve C, Bos P, Witkamp AJ, Ausems MG, van Diest PJ, van der Wall E. Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter study. PLoS ONE. 2015;10(5): e0127895.
Article
Google Scholar
Patuleia SIS, Hagenaars SC, Moelans CB, Ausems M, van Gils CH, Tollenaar R, van Diest PJ, Mesker WE, van der Wall E. Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(3):441–9.
Article
CAS
Google Scholar
van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH. Risk estimation for healthy women from breast cancer families: new insights and new strategies. Cancer Epidemiol Biomarkers Prev. 2004;13(1):87–93.
Article
Google Scholar
Sartorius OW. The biochemistry of breast cyst fluids and duct secretions. Breast Cancer Res Treat. 1995;35(3):255–66.
Article
CAS
Google Scholar
Patuleia SIS, van der Wall E, van Gils CH, Bakker MF, Jager A, Voorhorst-Ogink MM, van Diest PJ, Moelans CB. The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis. Cell Oncol (Dordr). 2021;44(6):1339–49.
Article
CAS
Google Scholar
Klein P, Glaser E, Grogan L, Keane M, Lipkowitz S, Soballe P, Brooks L, Jenkins J, Steinberg SM, DeMarini DM, Kirsch I. Biomarker assays in nipple aspirate fluid. Breast J. 2001;7(6):378–87.
Article
CAS
Google Scholar
Rosenkranz GK. A note on the Hodges-Lehmann estimator. Pharm Stat. 2010;9(2):162–7.
Article
Google Scholar
European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools https://cordis.europa.eu/project/id/765492. Accessed July 5 2021.
Jiwa N, Takats Z, Leff DR, Sutton C. Breast health screening: a UK-wide questionnaire. BMJ Nutr Prev Health. 2021;4(1):206–12.
Article
Google Scholar
Lee CI, Bassett LW, Leng M, Maliski SL, Pezeshki BB, Wells CJ, Mangione CM, Naeim A. Patients’ willingness to participate in a breast cancer biobank at screening mammogram. Breast Cancer Res Treat. 2012;136(3):899–906.
Article
Google Scholar
Jeukens C, van Dijk T, Berben C, Wildberger JE, Lobbes MBI. Evaluation of pressure-controlled mammography compression paddles with respect to force-controlled compression paddles in clinical practice. Eur Radiol. 2019;29(5):2545–52.
Article
CAS
Google Scholar
de Groot JE, Branderhorst W, Grimbergen CA, den Heeten GJ, Broeders MJM. Towards personalized compression in mammography: a comparison study between pressure- and force-standardization. Eur J Radiol. 2015;84(3):384–91.
Article
Google Scholar
LETB: Resultaten bevolkingsonderzoek borstkanker 2019 (over 2004–2014) https://www.rivm.nl/documenten/letb-resultaten-bevolkingsonderzoek-borstkanker-2019-over-2004-2014. Accessed December 21 2021.
de Lange SV, Bakker MF, Monninkhof EM, Peeters PHM, de Koekkoek-Doll PK, Mann RM, Rutten M, Bisschops RHC, Veltman J, Duvivier KM, Lobbes MBI, de Koning HJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, van Gils CH. Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts. Clin Radiol. 2018;73(8):759 e1-759 e9.
Article
Google Scholar
Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ. Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017;11:199–204.
Article
Google Scholar
Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, Pisano ED, Evans WP 3rd, Mahoney MC, Hovanessian Larsen L, Gabrielli GJ, Mendelson EB. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010;254(1):79–87.
Article
Google Scholar
Geuzinge HA, Heijnsdijk EAM, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA, Fa Msg. Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk. Breast. 2021;56:1.
Article
Google Scholar
Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM, Leach MO, Study UKSGfMSiWaHR. Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study. Br J Cancer. 2011;104(4):578–86.
Article
CAS
Google Scholar